atazanavir sulfate has been researched along with camptothecin in 1 studies
Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (camptothecin) | Trials (camptothecin) | Recent Studies (post-2010) (camptothecin) |
---|---|---|---|---|---|
1,102 | 246 | 590 | 13,002 | 2,229 | 5,391 |
Protein | Taxonomy | atazanavir sulfate (IC50) | camptothecin (IC50) |
---|---|---|---|
Histone deacetylase 3 | Homo sapiens (human) | 0.05 | |
Multidrug resistance-associated protein 4 | Homo sapiens (human) | 7.4 | |
DNA topoisomerase 1 | Homo sapiens (human) | 1.9799 | |
Somatostatin receptor type 1 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 2 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 4 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 3 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 5 | Homo sapiens (human) | 0.0022 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.97 | |
Histone deacetylase 4 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 1 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 7 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 2 | Homo sapiens (human) | 0.05 | |
Polyamine deacetylase HDAC10 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 11 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 8 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 6 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 9 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 5 | Homo sapiens (human) | 0.05 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ehmer, U; Lankisch, TO; Manns, MP; Strassburg, CP | 1 |
1 review(s) available for atazanavir sulfate and camptothecin
Article | Year |
---|---|
Family 1 uridine-5'-diphosphate glucuronosyltransferases (UGT1A): from Gilbert's syndrome to genetic organization and variability.
Topics: Antineoplastic Agents, Phytogenic; Atazanavir Sulfate; Bilirubin; Camptothecin; Genetic Variation; Gilbert Disease; Glucuronosyltransferase; HIV Protease Inhibitors; Humans; Irinotecan; Isoenzymes; Jaundice; Neoplasms; Oligopeptides; Pharmacogenetics; Pyridines; Risk Factors; Terminology as Topic | 2008 |